Claim Missing Document
Check
Articles

Found 2 Documents
Search

Leprosy Reactions and Nerve Damage in Children and Adolescents: A Pediatric Evidence Synthesis with Verified Cohort Findings Renni Yuniati; Farah Chilwa Hidayati; Muhammad Auzinal Haq
Jurnal Health Sains Vol. 7 No. 9 (2026): Journal Health Sains
Publisher : Syntax Corporation Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.46799/jhs.v7i9.2878

Abstract

Leprosy in childhood is an indicator of ongoing transmission and may be complicated by inflammatory reactions, neuritis, and disability. Antimicrobial treatment is essential; however, completion of therapy alone does not guarantee the preservation of nerve function. Pediatric evidence remains dispersed across small observational cohorts, with inconsistencies in denominators and outcome definitions. This study prepared a pediatric evidence synthesis using publicly accessible full-text cohort reports that provided verifiable numerators and denominators for reactions, neuritis, nerve damage, or disability outcomes. The synthesis was structured according to PRISMA 2020 guidelines. Studies were eligible if they included children younger than 15 years with leprosy and reported clinically defined outcomes during diagnosis, multidrug therapy, or follow-up. Two Brazilian prospective cohorts from referral units were verified through full-text review. In a 2019 cohort, 18 of 34 children (52.9%) experienced a leprosy reaction and/or isolated neuritis; among these, 14 of 18 (77.8%) had type 1 reactions, 14 of 18 (77.8%) experienced two or more episodes, and 6 of 18 (33.3%) developed complications. In a 2024 two-year cohort, 38 of 77 children (49.3%) experienced reactions; among these 38 children, 16 (42.1%) showed progression with worsening nerve damage. At diagnosis, 29 of 38 children (76.3%) had nerve damage, 20 (52.6%) had physical disability, and 11 (28.9%) had grade 2 disability. The verified cohorts indicate a substantial burden of leprosy reactions and nerve impairment among children treated in referral settings. Reactions occurred both during and after multidrug therapy, highlighting the importance of continued neurological surveillance beyond the completion of antimicrobial treatment.
Diagnostic Evaluation of Leprosy in Children and Adolescents: A Pediatric Evidence Synthesis on Clinical, Microscopic, Molecular, and Serological Testing Renni Yuniati; Farah Chilwa Hidayati; Muhammad Auzinal Haq
Al Makki Health Informatics Journal Vol. 4 No. 5 (2026): Al Makki Health Informatics Journal
Publisher : Al Makki Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.57185/ev4pc240

Abstract

Leprosy remains a significant infectious disease that can cause permanent disability, particularly when diagnosis is delayed. Pediatric leprosy presents unique diagnostic challenges due to nonspecific clinical manifestations, difficulties in neurological examination, and variations in the performance of available diagnostic methods. Accurate interpretation of clinical, microscopic, molecular, and serological tests is essential to support early detection and appropriate management. This study aims to synthesize current evidence regarding diagnostic approaches for leprosy in children and adolescents and to evaluate the roles, advantages, and limitations of available diagnostic methods. This study employed an evidence synthesis approach based on diagnostic accuracy concepts and reviewed relevant studies evaluating clinical examination, slit-skin smear, bacilloscopy, histopathology, molecular assays, and serological tests in pediatric leprosy. The evaluation considered participant characteristics, specimen types, reference standards, and methodological quality of diagnostic studies. The findings indicate that clinical examination remains the primary diagnostic approach, while laboratory methods provide complementary evidence depending on clinical conditions. Microscopic methods are more useful in patients with higher bacillary loads, whereas molecular techniques may assist diagnosis in uncertain cases but require careful interpretation based on specimen and assay characteristics. Serological tests are valuable for assessing exposure or risk but cannot independently confirm active disease. However, substantial heterogeneity in study designs and reference standards prevents reliable pooled diagnostic performance estimation. Pediatric leprosy diagnosis requires an integrated and context-based approach. Future research should establish standardized diagnostic pathways using representative pediatric populations, independent reference standards, and comprehensive reporting methods to improve diagnostic accuracy and clinical outcomes.